1. Home
  2. XNCR vs DCOM Comparison

XNCR vs DCOM Comparison

Compare XNCR & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • DCOM
  • Stock Information
  • Founded
  • XNCR 1997
  • DCOM 1864
  • Country
  • XNCR United States
  • DCOM United States
  • Employees
  • XNCR N/A
  • DCOM N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • DCOM Major Banks
  • Sector
  • XNCR Health Care
  • DCOM Finance
  • Exchange
  • XNCR Nasdaq
  • DCOM Nasdaq
  • Market Cap
  • XNCR 1.1B
  • DCOM 1.2B
  • IPO Year
  • XNCR 2013
  • DCOM 1996
  • Fundamental
  • Price
  • XNCR $13.86
  • DCOM $26.90
  • Analyst Decision
  • XNCR Buy
  • DCOM Strong Buy
  • Analyst Count
  • XNCR 11
  • DCOM 3
  • Target Price
  • XNCR $23.50
  • DCOM $34.17
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • DCOM 232.1K
  • Earning Date
  • XNCR 11-05-2025
  • DCOM 10-23-2025
  • Dividend Yield
  • XNCR N/A
  • DCOM 3.71%
  • EPS Growth
  • XNCR N/A
  • DCOM N/A
  • EPS
  • XNCR N/A
  • DCOM 1.18
  • Revenue
  • XNCR $150,132,000.00
  • DCOM $340,529,000.00
  • Revenue This Year
  • XNCR $22.09
  • DCOM $52.73
  • Revenue Next Year
  • XNCR N/A
  • DCOM $16.33
  • P/E Ratio
  • XNCR N/A
  • DCOM $22.92
  • Revenue Growth
  • XNCR 38.16
  • DCOM 8.54
  • 52 Week Low
  • XNCR $6.92
  • DCOM $23.25
  • 52 Week High
  • XNCR $27.24
  • DCOM $37.60
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 54.01
  • DCOM 41.48
  • Support Level
  • XNCR $13.30
  • DCOM $25.75
  • Resistance Level
  • XNCR $15.16
  • DCOM $26.87
  • Average True Range (ATR)
  • XNCR 1.14
  • DCOM 0.80
  • MACD
  • XNCR -0.18
  • DCOM -0.04
  • Stochastic Oscillator
  • XNCR 50.22
  • DCOM 29.28

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About DCOM Dime Community Bancshares Inc.

Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.

Share on Social Networks: